Acquired haemophilia (AH) is a bleeding diathesis caused by inhibitors to factor VIII. Patients developing AH may present with catastrophic bleeding episodes despite having no prior history of bleeding disorder. The authors report a patient with AH who presented with tongue swelling and was diagnosed with angioedema on presentation. However, the patient started bleeding spontaneously after presentation and was diagnosed with AH and the workup revealed haematoma of the tongue, which was the cause of tongue swelling. As previously reported in the literature, AH in this patient might have been precipitated secondary to exposure to an ear infection or exposure to the penicillin group of antibiotics. Laboratory examination was confirmatory for AH, which was appropriately treated with recombinant activated factor VIIa and immunosuppressive therapy with good outcomes. Understanding the pathophysiology of AH and appropriate management is important to prevent life-threatening bleeding.
Phenazopyridine is commonly used for its local analgesic effects on the urinary tract. It is taken with antibiotics for a short time, typically 2 days, to treat dysuria associated with urinary tract infections. Adverse reactions associated with phenazopyridine are limited and include mild gastrointestinal symptoms, headache, and dizziness, but in rare cases, patients can develop severe and life-threatening adverse reactions such as acute renal failure, hemolytic anemia, hepatitis, and methemoglobinemia. 1 We report a case of an elderly patient who developed phenazopyridine-induced toxicity while taking an appropriate dose of phenazopyridine for an extended duration of time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.